15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 10.4% per year over the past 5 years.
Operating margin has contracted, at -7.1% in the latest year.
Financial health
Total debt ($3.2B) exceeds cash ($1.6B); net debt is $1.6B.
Total debt has grown slower than revenue (-2.2% vs 10.4% per year).
Operating income covered interest expense -1.8× in the latest year, down from 6.9× 5 years ago.
Total debt is 11× EBITDA.
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 27.5% of free cash flow.
The dividend has grown 3.3% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$5.1B
-$511M
13.0%
-7.1%
$692M
$3.2B
$1.6B
2024
$5.4B
-$1.2B
1.2%
-33.0%
-$993M
$3.5B
$1.2B
2023
$9.6B
$1.6B
12.3%
2.6%
-$828M
$4.2B
$890M
2022
$7.3B
$2.7B
42.0%
33.7%
$651M
$3.2B
$1.5B
2021
$3.3B
$124M
30.0%
24.0%
-$609M
$2.4B
$439M
2020
$3.1B
$376M
31.8%
16.2%
-$52M
$3.6B
$747M
2019
$3.6B
$533M
35.0%
18.6%
-$132M
$3.1B
$613M
2018
$3.4B
$694M
36.1%
27.0%
-$154M
$1.7B
$555M
2017
$3.1B
$55M
36.0%
18.6%
-$14M
$1.8B
$1.1B
2016
$2.7B
$644M
36.2%
22.4%
$539M
$2.4B
$2.3B
2015
—
$335M
—
—
$133M
$3.8B
$214M
2014
—
$133M
—
—
$382M
$3.3B
$2.5B
2013
—
$413M
—
—
$278M
$1.1B
$477M
2012
—
$312M
—
—
$208M
$699M
$478M
2011
—
$392M
—
—
$297M
$764M
$469M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$1.4B
$319M
35.1%
16.3%
$248M
$1.9B
$1.1B
Dec '25
$1.4B
-$414M
13.9%
-15.2%
$233M
$3.2B
$1.6B
Sep '25
$1.3B
-$161M
9.0%
-16.6%
$223M
$3.6B
$1.9B
Jun '25
$1.3B
$23M
14.8%
3.6%
-$127M
$3.6B
$1.8B
Mar '25
$1.1B
$41M
14.5%
1.8%
$365M
$3.5B
$1.5B
Dec '24
$1.2B
$75M
11.2%
0.4%
-$347M
$3.5B
$1.2B
Sep '24
$1.4B
-$1.1B
-7.7%
-81.9%
-$76M
$3.6B
$1.7B
Jun '24
$1.4B
-$188M
-0.7%
-34.4%
-$88M
$3.5B
$1.8B
Mar '24
$1.4B
$2M
2.9%
-13.2%
-$481M
$3.5B
$2.1B
Dec '23
$2.4B
-$618M
-29.9%
-36.1%
-$782M
$4.2B
$890M
Sep '23
$2.3B
$303M
2.4%
-6.1%
$83M
$3.7B
$1.6B
Jun '23
$2.4B
$650M
23.6%
5.9%
-$430M
$3.5B
$1.6B
Mar '23
$2.6B
$1.2B
49.5%
42.7%
$305M
$3.2B
$1.6B
Dec '22
$2.6B
$1.1B
38.2%
31.8%
$507M
$3.2B
$1.5B
Sep '22
$2.1B
$897M
49.9%
42.6%
$582M
$3.4B
$1.4B
Jun '22
$1.5B
$407M
39.2%
29.3%
-$417M
$3.5B
$931M
Mar '22
$1.1B
$253M
39.8%
27.7%
-$26M
$2.5B
$463M
Dec '21
$894M
-$4M
26.5%
-3.5%
-$447M
$2.4B
$439M
Sep '21
$831M
-$393M
30.0%
15.8%
-$151M
$2.0B
$595M
Jun '21
$774M
$425M
32.1%
70.1%
$11M
$2.0B
$824M
Valuation over time
How the market has priced ALB against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 9.7× (Mar '23) to 8.1× (Nov '24).
The price-to-sales ratio has fallen from 3.6× (Mar '23) to 3.2× (Jun '26).
The dividend yield has risen from 0.7% (Mar '23) to 1.1% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is ALB growing its revenue and profit?
Over the past 5 years, Albemarle's revenue has grown 10.4% per year. These are computed facts, not advice.
How much debt does ALB have?
As of FY2025, Albemarle reported $3.2B of total debt against $1.6B of cash; operating income covered interest expense -1.8×.
What is ALB's profit margin?
In FY2025, gross margin was 13.0%, operating margin -7.1%, and net margin -9.9%.
What is ALB's P/E ratio?
As of Jun '26, Albemarle traded at a price-to-earnings ratio of about 8.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.